Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy

BACKGROUND: Patients with pancreatic ductal adenocarcinoma (PDAC) who undergo surgical resection and receive effective chemotherapy have the best chance for long‐term survival. Unfortunately, because of the heterogeneity of pancreatic cancer, it is difficult to find a personalized treatment strategy...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Miaomiao, Meng, Han, Tan, Dengxu, Li, Peng, Qin, Jing, An, Qingling, Shi, Changhong, An, Jiaze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Themed Section: Usage of Different Tumor Models in Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614126/
https://www.ncbi.nlm.nih.gov/pubmed/37890865
http://dx.doi.org/10.1002/ame2.12352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614126/
https://www.ncbi.nlm.nih.gov/pubmed/37890865
http://dx.doi.org/10.1002/ame2.12352

Ejemplares similares